The management of early laryngeal cancer: Options for patients and therapists

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 13, Issue 2, 2005, Pages 85-91

  Back, Gary ^a   Sood, Sanjai ^a  

^a BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Early laryngeal cancer; Radiotherapy; Surgery; Treatment

Indexed keywords

CISPLATIN; FLUOROURACIL;

ACUTE TOXICITY; ANTERIOR COMMISSURE; CANCER RISK; CANCER THERAPY; CHEMOTHERAPY; ENDOSCOPIC SURGERY; FRACTIONATION; HEALTH CARE COST; HOME CARE; HUMAN; LARYNGECTOMY; LARYNX CANCER; LASER SURGERY; MEDICAL DECISION MAKING; MORBIDITY; PATIENT CARE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SALVAGE THERAPY; TREATMENT OUTCOME; VOICE;

ENDOSCOPY; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPHATIC METASTASIS; PHOTOCHEMOTHERAPY; QUALITY OF LIFE; TREATMENT OUTCOME; VOICE QUALITY;

EID: 15244340844     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000156168.63204.70     Document Type: Review

References (51)

1. Lee DJ. Definitive radiotherapy for squamous carcinoma of the larynx. Otolaryngol Clin North Am 2002; 32:1013-1033.
2. The Royal College of Surgeons of England, London. Effective Head &Neck Cancer Management: Second Consensus Document 2000, British Association of Otorhinolaryngologists, Head and Neck Surgeons.
3. Groome PA, O'Sullivan B, Irish JC, et al. Glottic cancer in Ontario, Canada and the SEER areas of the United States: do different management philosophies produce different outcome profiles? J Clin Epidemiol 2001; 54:301-315.
4. American Joint Committee on Cancer. Manual for Staging of Cancer, edn. 4. Philadelphia: JB Lippincott; 1992.
5. Ferlito A, Bradley PJ, Rinaldo A. What is the treatment of choice for T1 squamous cell carcinoma of the larynx? J Laryngol Otol 2004; 118:747-749.
6. Franchin G, Minatel E, Gobitti C, et al. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer 2003; 98:765-772.
7. Barthel SW, Esclamado RM. Primary radiation therapy for early glottic cancer. Otolaryngol Head Neck Surg 2001; 124:35-39.
8. Lee JH, Machtay M, McKenna MG, et al. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord. Am J Otolaryngol 2001; 22:43-54.
9. Gowda RV, Henk JM, Mais KL, et al. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital experience. Radiother Oncol 2003; 68:105-111.
10. Chen MF, Chang JT, Tsang NM, et al. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis. Ann Otol Rhinol Laryngol 2003; 112:904-911.
11. Zouhair A, Azria D, Couck P, et al. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension. Strahlenther Onkol 2004; 180:84-90.
12. Hinerman RW, Mendenhall WM, Amdur RJ, et al. Early laryngeal cancer. Curr Treat Options Oncol 2002; 3:3-9.
13. Mendenhall WM, Werning JW, Hinerman RW, et al. Management of T1-T2 glottic carcinomas. Cancer 2004; 100:1786-1792. This review of the management of early glottic cancer provides a good discussion of the shortcomings of studies and why it is difficult to compare studies.
14. Haugen H, Johansson KA, Mercke C. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. Int J Radiat Oncol Biol Phys 2002; 52:109-119.
15. Stoeckli SJ, Schnieper I, Huguenin P, et al. Early glottic carcinoma: treatment according to patient's preference? Head Neck 2003; 25:1051-1056.
16. Garden AS, Forster K, Wong PF, et al. Results of radiotherapy for T2N0 glottic carcinoma: does the '2' stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 2003; 55:322-328.
17. Gallo A, de Vincentiis M, Manciocco V, et al. CO2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope 2002; 112:370-374.
18. Smith JC, Johnson JT, Myers EN. Management and outcome of early glottic carcinoma. Otolaryngol Head Neck Surg 2002; 126:356-364.
19. Eckel HE: Local recurrences following transoral laser surgery for early glottic carcinoma: frequency, management, and outcome. Ann Otol Rhinol Laryngol 2001; 110:7-15.
20. Pradhan SA, Pai PS, Neeli SI, et al. Transoral laser surgery for early glottic cancers. Arch Otolaryngol Head Neck Surg 2003; 129:623-625.
21. Zeitels SM, Hillman RE, Franco RA, et al. Voice and treatment outcome from phonosurgical management of early glottic cancer. Ann Otol Rhinol Laryngol Suppl 2002; 190:3-20.
22. Steiner W, Ambrosch P, Rodel RM, et al. Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope 2004; 114:1485-1491.
23. Brandenburg JH. Laser cordotomy versus radiotherapy: an objective cost analysis. Ann Otol Rhinol Laryngol 2001; 110:312-318.
24. Peretti G, Piazza C, Balzanelli C, et al. Vocal outcome after endoscopic cordectomies for Tis and T1 glottic carcinomas. Ann Otol Rhinol Laryngol 2003; 112:174-179.
25. Jones AS, Fish B, Fenton JE, et al. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation? Head Neck 2004; 26:127-135.
26. Markou K, Nikolaou A, Nalbadian M, et al. How often is total laryngectomy necessary for the treatment of T1 failures after radiotherapy or cordectomy? Eur Arch Otorhinolaryngol 2002; 259:4-10.
27. Kehrl W, Tolkemitt J, Dusterhus P. Comparison between transoral microsurgery by CO2 laser and conventional surgical therapy for T2 glottic carcinoma. Laryngorhinootologie 2003; 82:189-194.
28. Davis RK, Hadley K, Smith ME. Endoscopic vertical partial laryngectomy. Laryngoscope 2004; 114:236-240.
29. Flint PW. Minimally invasive techniques for management of early glottic cancer. Otolaryngol Clin North Am 2002; 35:1055-1066.
30. Giovanni A, Guelfucci B, Gras R, et al. Partial frontolateral laryngectomy with epiglottic reconstruction for management of early-stage glottic carcinoma. Laryngoscope 2001; 111:663-668.
31. Schweitzer VG. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 2001; 29:305-313.
32. Biel MA. Photodynamic therapy in head and neck cancer. Curr Oncol Rep 2002; 4:87-96.
33. Laccourreye O, Veivers D, Bassot V, et al. Analysis of local recurrence in patients with selected T1-T3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure. Ann Otol Rhinol Laryngol 2002; 111:315-322.
34. The Royal College of Surgeons of England, London. Effective Head and Neck Cancer Management: Third Consensus Document 2002, British Association of Otorhinolaryngologists, Head and Neck Surgeons.
35. Orus C, Leon X, Vega M, et al. Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy. Eur Arch Otorhinolaryngol 2000; 257:512-516.
36. Hinerman RW, Mendenhall WM, Andur RJ, et al. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002; 24:456-467.
37. Tufano RP. Organ preservation surgery for laryngeal cancer. Otolaryngol Clin N Am 2002; 35:1067-1080.
38. Mendenhall WM, Parsons JT, Mancuso AA, et al. Radiotherapy for carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 1996; 18:24-35.
39. Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic cancer. Ann Otol Rhinol Laryngol 1998; 107:680-688.
40. Davis RK, Kriskovich MD, Galloway EB, et al. Endoscopic supraglottic laryngectomy with postoperative irradiation. Ann Otol Rhinol Laryngol 2004; 113:132-138.
41. Santoro R. Turelli M, Polli G: Primary carcinoma of the subglottic larynx. Eur Arch Otorhinolaryngol 2000; 257:548-551.
42. Stoeckli SJ, Guidicelli M, Schneider A, et al. Quality of life after treatment of early laryngeal cancer. Eur Arch Otorhinolaryngol 2001; 258:96-99.
43. Leeper HA, Parsa V, Jamieson G, et al. Acoustical aspects of vocal function following radiotherapy for early T1 a laryngeal cancer. J Voice 2002; 16:289-302.
44. Wedman J, Heimdal JH, Elstad I, et al. Voice results in patients with T1 a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol 2002; 259:547-550.
45. Peretti G, Piazza C, Balzanelli C, et al. Preoperative and postoperative voice in Tis-T1 glottic cancer treated by endoscopic cordectomy: an additional issue for patient counseling. Ann Otol Rhinol Laryngol 2003; 112:759-763.
46. Jepsen MC, Gurushanthaiah D, Roy N, et al. Voice, speech and swallowing in laser-treated laryngeal cancer. Laryngoscope 2003; 113:923-928.
47. McGuirt WF, Blalok D, Kouffman JA, et al. Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg 1994; 120:951-955.
48. Smith JC, Johnson JT, Cognetti DM, et al. Quality of life, functional outcome, and costs in early glottic cancer. Laryngoscope 2003; 113:68-76.
49. Dinardo LJ, Kaylie DM: Isaacson J. Current treatment practices for early laryngeal carcinoma. Otolaryngol Head Neck Surg 1999; 120:30-37.
50. Gregoire V, Hamoir M, Rosier JF, et al. Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Radiother Oncol 1999; 53:1-13.
51. Dey P, Arnold D, Wight R, et al. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer (Cochrane Review). The Cochrane Library, issue 3, 2004. Chichester, UK; John Wiley & Sons, Ltd. This systematic review documents the lack of prospective evidence in the management of early glottic cancer.